SITS (Safe Implementation of Treatments in Stroke) Open Artery by Thrombectomy in Acute Occlusive Stroke Study
Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
Ischemic stroke, i.e. irreversible damage of a part of the patient's brain, is caused by the
formation of blood clot in the major vessel which gives blood supply to a certain part of the
brain. At early time, within the first 4,5 hours, the conventional treatment is to try to
dissolve this blood clot with a medication ("thrombolytic drug") which is administered to the
blood through the needle in the vein. If the clot still remains there, additional treatment
is possible - going directly to the clot via artery and taking it out with a special device.
Patients may be included even if they are not treated with intravenous thrombolysis because
of contraindication or other reasons. The purpose of the present study is to evaluate the
benefit and safety efficacy of thrombectomy and standard stroke care in clinical routine
treatment of acute occlusive stroke compared to standard stroke care only.
Phase:
N/A
Details
Lead Sponsor:
Karolinska Institutet
Collaborators:
Medtronic - MITG Phenox GmbH Stryker Nordic Swedish Heart Lung Foundation